Comparative outcome and prognostic factor analysis among MDS/AML patients with TP53 mutations, snps, and wild type
Abstract While variant TP53 is an adverse prognosis factor in myelodysplastic syndromes (MDS)/acute myeloid leukemia (AML), current clinical prognosis and variation feature analysis of TP53 alterations remain limited. We evaluated 333 MDS/AML patients with TP53 mutations, single nucleotide polymorph...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMC
2025-08-01
|
| Schriftenreihe: | Human Genomics |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1186/s40246-025-00792-z |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|